Connection

WILLIAM MITCH to Muscle, Skeletal

This is a "connection" page, showing publications WILLIAM MITCH has written about Muscle, Skeletal.
Connection Strength

5.162
  1. Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease. Am J Physiol Renal Physiol. 2020 07 01; 319(1):F84-F92.
    View in: PubMed
    Score: 0.436
  2. Stat3 activation induces insulin resistance via a muscle-specific E3 ubiquitin ligase Fbxo40. Am J Physiol Endocrinol Metab. 2020 05 01; 318(5):E625-E635.
    View in: PubMed
    Score: 0.428
  3. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem. 2015 Apr 24; 290(17):11177-87.
    View in: PubMed
    Score: 0.304
  4. Can muscle-kidney crosstalk slow progression of CKD? J Am Soc Nephrol. 2014 Dec; 25(12):2681-3.
    View in: PubMed
    Score: 0.290
  5. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014 Sep; 10(9):504-16.
    View in: PubMed
    Score: 0.289
  6. Muscle wasting from kidney failure-a model for catabolic conditions. Int J Biochem Cell Biol. 2013 Oct; 45(10):2230-8.
    View in: PubMed
    Score: 0.270
  7. Signal regulatory protein-a interacts with the insulin receptor contributing to muscle wasting in chronic kidney disease. Kidney Int. 2013 Aug; 84(2):308-16.
    View in: PubMed
    Score: 0.264
  8. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J. 2011 May; 25(5):1653-63.
    View in: PubMed
    Score: 0.228
  9. PTEN inhibition improves muscle regeneration in mice fed a high-fat diet. Diabetes. 2010 Jun; 59(6):1312-20.
    View in: PubMed
    Score: 0.214
  10. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010 Apr; 91(4):1128S-1132S.
    View in: PubMed
    Score: 0.214
  11. Chemokine CXCL16 regulates neutrophil and macrophage infiltration into injured muscle, promoting muscle regeneration. Am J Pathol. 2009 Dec; 175(6):2518-27.
    View in: PubMed
    Score: 0.209
  12. PTEN expression contributes to the regulation of muscle protein degradation in diabetes. Diabetes. 2007 Oct; 56(10):2449-56.
    View in: PubMed
    Score: 0.178
  13. Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease. J Ren Nutr. 2007 Jan; 17(1):66-9.
    View in: PubMed
    Score: 0.172
  14. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol. 2006 May; 17(5):1388-94.
    View in: PubMed
    Score: 0.164
  15. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest. 2004 Jan; 113(1):115-23.
    View in: PubMed
    Score: 0.140
  16. Systemic inflammation is associated with exaggerated skeletal muscle protein catabolism in maintenance hemodialysis patients. JCI Insight. 2017 11 16; 2(22).
    View in: PubMed
    Score: 0.091
  17. Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys. Nat Commun. 2017 11 14; 8(1):1493.
    View in: PubMed
    Score: 0.091
  18. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017 01; 91(1):119-128.
    View in: PubMed
    Score: 0.084
  19. Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int J Obes (Lond). 2016 Mar; 40(3):434-442.
    View in: PubMed
    Score: 0.079
  20. Adverse Effects of Sporadic Dialysis on Body Composition. Nephron. 2015; 131(1):73-7.
    View in: PubMed
    Score: 0.078
  21. MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways. Aging (Albany NY). 2014 Mar; 6(3):160-75.
    View in: PubMed
    Score: 0.071
  22. Stat3 activation links a C/EBPd to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013 Sep 03; 18(3):368-79.
    View in: PubMed
    Score: 0.068
  23. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia. Int J Biochem Cell Biol. 2013 Oct; 45(10):2322-32.
    View in: PubMed
    Score: 0.067
  24. Angiotensin II upregulates protein phosphatase 2Ca and inhibits AMP-activated protein kinase signaling and energy balance leading to skeletal muscle wasting. Hypertension. 2011 Oct; 58(4):643-9.
    View in: PubMed
    Score: 0.059
  25. Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J Biol Chem. 2010 Jul 09; 285(28):21249-57.
    View in: PubMed
    Score: 0.054
  26. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy. J Am Soc Nephrol. 2010 Mar; 21(3):419-27.
    View in: PubMed
    Score: 0.053
  27. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. J Clin Invest. 2009 Oct; 119(10):3059-69.
    View in: PubMed
    Score: 0.052
  28. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int. 2009 Oct; 76(7):751-9.
    View in: PubMed
    Score: 0.051
  29. Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions. J Am Soc Nephrol. 2006 Nov; 17(11):3233-9.
    View in: PubMed
    Score: 0.042
  30. Tissue-specific regulation of ubiquitin (UbC) transcription by glucocorticoids: in vivo and in vitro analyses. Am J Physiol Renal Physiol. 2007 Feb; 292(2):F660-6.
    View in: PubMed
    Score: 0.042
  31. Effect of bicarbonate on muscle protein in patients receiving hemodialysis. Am J Kidney Dis. 2006 Sep; 48(3):419-29.
    View in: PubMed
    Score: 0.042
  32. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006 Sep; 147(9):4160-8.
    View in: PubMed
    Score: 0.041
  33. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process. Int J Biochem Cell Biol. 2005 Oct; 37(10):2147-55.
    View in: PubMed
    Score: 0.039
  34. Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting. J Clin Invest. 2005 Feb; 115(2):451-8.
    View in: PubMed
    Score: 0.038
  35. The evidence against malnutrition as a prominent problem for chronic dialysis patients. Semin Dial. 2004 Nov-Dec; 17(6):427-31.
    View in: PubMed
    Score: 0.037
  36. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004 Jan; 18(1):39-51.
    View in: PubMed
    Score: 0.035
  37. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 2002 Apr; 61(4):1286-92.
    View in: PubMed
    Score: 0.031
  38. Ubiquitin (UbC) expression in muscle cells is increased by glucocorticoids through a mechanism involving Sp1 and MEK1. J Biol Chem. 2002 May 10; 277(19):16673-81.
    View in: PubMed
    Score: 0.031
  39. Pathophysiological mechanisms leading to muscle loss in chronic kidney disease. Nat Rev Nephrol. 2022 03; 18(3):138-152.
    View in: PubMed
    Score: 0.030
  40. Signal regulatory protein alpha initiates cachexia through muscle to adipose tissue crosstalk. J Cachexia Sarcopenia Muscle. 2019 12; 10(6):1210-1227.
    View in: PubMed
    Score: 0.026
  41. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013 Oct; 45(10):2333-47.
    View in: PubMed
    Score: 0.017
  42. Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile. Endocrinology. 2008 Feb; 149(2):827-35.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.